Medical Device Commercialization Services Market Size, Share, By Service Type (Regulatory Affairs, Market Access, Sales and Marketing, Clinical Affairs, and Business Development), By Device Type (Medical Imaging, In Vitro Diagnostics, Orthopedics, Cardiology, and Other), By Stage of Commercialization (Pre-launch, Launch, Growth, and Maturity), By End-User (Pharmaceutical Companies, Medical Device Companies, and Biotechnology Companies), and By Region - Trends, Analysis and Forecast till 2034

Report Code: PMI553224 | Publish Date: July 2024 | No. of Pages: 188

Medical Device Commercialization Services Market Companies

  • IQVIA
  • ICON plc
  • Covance Inc. (Labcorp)
  • Medpace, Inc.
  • Syneos Health
  • Parexel International Corporation
  • Charles River Laboratories International, Inc.
  • PRA Health Sciences
  • Wuxi AppTec
  • ProMedica International
  • NAMSA
  • Emergo by UL
  • Maetrics
  • Regulatory and Clinical Research Institute Inc. (RCRI)
  • Medtronic
  • Boston Scientific
  • Abbott Laboratories
  • Stryker Corporation
  • Johnson & Johnson
  • GE Healthcare

Recent News:

  • ProductLife Group (PLG), a specialized provider of regulatory, scientific, quality, and digital transformation consulting services to the life sciences industry, will acquire Australian company Commercial Eyes in February 2024. Commercial Eyes is a pharmaceutical and medical device commercialization business specializing in regulatory affairs, pharmacovigilance, medical information, quality assurance, market access, market research, and patient programs. PLG will be able to combine its global reach and expertise with Commercial Eyes' regional knowledge and talents, enabling it to offer clients more services and solutions. Joining PLG is a significant strategic decision for Commercial Eyes, its staff, and its clients. We intend to expand our global footprint by leveraging the infrastructure we've established over the last 22 years.
  • Herspiegel expanded its world-class commercialization services in December 2023 by forming a partnership with Adivo Associates (Adivo), an unparalleled specialty market data insights and analytics services provider. With this latest acquisition, the firm has broadened its service offering. It is uniquely positioned to provide life science organizations with a lens for specialty market development and monitoring, resulting in a faster launch and improved performance for in-line products. With Herspiegel's expanded Market Access and Medical Affairs practices, the combined business provides world-class commercialization services. This strategic agreement creates a team of over 150 people, increasing the firm's ability to serve clients globally. Herspiegel's impact will spread across the United States, Canada, Europe, and Latin America.